UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 356

Sortiert nach

The Role of Deferiprone in Iron Chelation

The New England journal of medicine, 2018-11, Vol.379 (22), p.2140-2150

2018

Volltextzugriff (PDF)

How I treat transfusional iron overload

Blood, 2012-11, Vol.120 (18), p.3657-3669

2012

Volltextzugriff (PDF)

Minimal residual disease is a significant predictor of treatment failure in non T‐lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993

British journal of haematology, 2010-01, Vol.148 (1), p.80-89

2010

Volltextzugriff (PDF)

The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment

Blood, 2010-11, Vol.116 (22), p.4569-4577

2010

Volltextzugriff (PDF)

Color Atlas of Clinical Hematology: Molecular and Cellular Basis of Disease

Fifth edition, 2019

Volltextzugriff (PDF)

Mandatory UK folic acid fortification

The Lancet (British edition), 2021-11, Vol.398 (10315), p.1961-1962

2021

Volltextzugriff (PDF)

2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells

Blood, 2009-08, Vol.114 (6), p.1217-1225

2009

Volltextzugriff (PDF)

Postgraduate Haematology

Seventh edition, 2015

Volltextzugriff (PDF)

p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism

Blood, 2008-11, Vol.112 (9), p.3827-3834

2008

Volltextzugriff (PDF)

The Role of Deferiprone in Iron Chelation. Reply

The New England journal of medicine, 2019-02, Vol.380 (9), p.892-893

2019

Volltextzugriff (PDF)

Professor John Scott, folate and neural tube defects

British journal of haematology, 2014-02, Vol.164 (4), p.496-502

Hoffbrand, A. Victor

2014

Volltextzugriff (PDF)

X-linked Sideroblastic Anemia Due to Carboxyl-terminal ALAS2 Mutations That Cause Loss of Binding to the β-Subunit of Succinyl-CoA Synthetase (SUCLA2)

The Journal of biological chemistry, 2012-08, Vol.287 (34), p.28943-28955

2012

Volltextzugriff (PDF)

Role of deferiprone in chelation therapy for transfusional iron overload

Blood, 2003-07, Vol.102 (1), p.17-24

2003

Volltextzugriff (PDF)

Fludarabine, cytosine arabinoside, granulocyte‐colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes

British journal of haematology, 2004-01, Vol.124 (1), p.26-32

2004

Volltextzugriff (PDF)

Is “leukemia” an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia?

Leukemia research, 2007-03, Vol.31 (3), p.273-275

2007

Volltextzugriff (PDF)

Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis

Blood, 2003-04, Vol.101 (8), p.3174-3180

2003

Volltextzugriff (PDF)

Iron deficiency and overload

Hematology, 2003, Vol.2003 (1), p.40-61

2003

Volltextzugriff (PDF)

Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia

Haematologica (Roma), 2005-05, Vol.90 (5), p.585-595

2005

Volltextzugriff (PDF)

Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients

British journal of haematology, 2003-04, Vol.121 (1), p.187-189

2003

Volltextzugriff (PDF)

Deferiprone therapy for transfusional iron overload

Best practice & research. Clinical haematology, 2005-06, Vol.18 (2), p.299-317

Victor Hoffbrand, A.

2005

Volltextzugriff (PDF)

Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpura

British journal of haematology, 2002-06, Vol.117 (3), p.712-715

2002

Volltextzugriff (PDF)

Two new mutations in the HIF2A gene associated with erythrocytosis

American journal of hematology, 2012-04, Vol.87 (4), p.439-442

2012

Volltextzugriff (PDF)

Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism

Oncogene, 1999-04, Vol.18 (15), p.2499-2506

1999

Volltextzugriff (PDF)

Minimal Residual Disease Tests Provide an Independent Predictor of Clinical Outcome in Adult Acute Lymphoblastic Leukemia

Journal of clinical oncology, 2002-02, Vol.20 (4), p.1094-1104

Mortuza, F. Y.

2002

Volltextzugriff (PDF)

Clinical trial of deferiprone iron chelation therapy in β‐thalassaemia/haemoglobin E patients in Thailand

British journal of haematology, 2003-07, Vol.122 (2), p.305-310

2003

Volltextzugriff (PDF)

1 – 25 von 356

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(249)
Mit Volltextzugriff
(321)

Publikationsform

Artikel
(256)
Buchkapitel
(93)
Bücher
(4)
Berichte
(3)

Sprache

Englisch
(356)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Life Sciences & Biomedicine
(176)
Humans
(161)
Hematology
(140)
Biological And Medical Sciences
(106)
Medical Sciences
(91)
Male
(59)
Clinical & Internal Medicine
(58)
Hematologic And Hematopoietic Diseases
(56)
Female
(55)
Adult
(52)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(47)
Middle Aged
(40)
Oncology
(36)
Aged
(32)
Pharmacology. Drug Treatments
(29)
Adolescent
(28)
Child
(23)
Antineoplastic Agents
(17)
Cells, Cultured
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(39)
Reviews In Clinical And Experimental Hematology
(38)
British Journal Of Haematology
(37)
Leukemia Research
(23)
Febs Letters
(11)
Leukemia & Lymphoma
(8)
Haematologica
(6)
The Lancet
(6)
Biochimica Et Biophysica Acta
(5)
European Journal Of Immunology
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Role of Deferiprone in Iron Chelation

How I treat transfusional iron overload

Minimal residual disease is a significant predictor of treatment failure in non T‐lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993

The JAK3-selective inhibitor PF-956980 reverses the resistance to cytotoxic agents induced by interleukin-4 treatment of chronic lymphocytic leukemia cells: potential for reversal of cytoprotection by the microenvironment

Color Atlas of Clinical Hematology: Molecular and Cellular Basis of Disease

Mandatory UK folic acid fortification

2-phenylacetylenesulfonamide (PAS) induces p53-independent apoptotic killing of B-chronic lymphocytic leukemia (CLL) cells

Postgraduate Haematology

p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism

The Role of Deferiprone in Iron Chelation. Reply

Professor John Scott, folate and neural tube defects

X-linked Sideroblastic Anemia Due to Carboxyl-terminal ALAS2 Mutations That Cause Loss of Binding to the β-Subunit of Succinyl-CoA Synthetase (SUCLA2)

Role of deferiprone in chelation therapy for transfusional iron overload

Fludarabine, cytosine arabinoside, granulocyte‐colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes

Is “leukemia” an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia?

Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis

Iron deficiency and overload

Role of autoimmune gastritis, Helicobacter pylori and celiac disease in refractory or unexplained iron deficiency anemia

Comparison between desferrioxamine and combined therapy with desferrioxamine and deferiprone in iron overloaded thalassaemia patients

Deferiprone therapy for transfusional iron overload

Mycophenolate mofetil for the treatment of refractory auto‐immune haemolytic anaemia and auto‐immune thrombocytopenia purpura

Two new mutations in the HIF2A gene associated with erythrocytosis

Ceramide-induced killing of normal and malignant human lymphocytes is by a non-apoptotic mechanism

Minimal Residual Disease Tests Provide an Independent Predictor of Clinical Outcome in Adult Acute Lymphoblastic Leukemia

Clinical trial of deferiprone iron chelation therapy in β‐thalassaemia/haemoglobin E patients in Thailand

Suchergebnisse filtern